New cholesterol drug VSA003 passes first safety check in healthy people
NCT ID NCT05851066
First seen Nov 01, 2025 · Last updated May 05, 2026 · Updated 26 times
Summary
This early-stage study tested a single dose of VSA003 in 36 healthy Chinese adults to see if it is safe and how the body processes it. Participants had slightly high cholesterol or triglycerides. The goal was not to treat disease but to gather safety and drug-level data before moving to patient studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.